Effect of Stevia Leave Powder on Blood Glucose and Lipid Profile of Diabetic Patients
Launched by UNIVERSITY OF LAHORE · Oct 15, 2024
Trial Information
Current as of June 10, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The selected participants will be randomly divided into placebo and treatment groups. The Initial (0-Day) data on anthropometric measurements and blood analysis on glucose, lipid levels and liver function tests (LFTs) will be carried out.
The balance diet plan will be prepared according to Pakistan dietary guidelines and given to all the study participants. Treatment stevia powder capsules will be provided to the participants for 7 days and for 60 days for short and long-term study respectively, for monitoring of compliance. Anthropometric measurements and biochemical assessments like bloo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Inclusion Criteria: Individuals with the following conditions will be included as participants;
- • Patients of type 2 diabetes mellitus with the age range between 25-35 years from both genders
- • Diabetic patients without anti-diabetic drugs and their duration of diabetes no longer than 6 months
- • Diabetic patients with HbA1c \>6% and blood sugar level \>200 mg/dL
- Exclusion Criteria:
- • Individuals with the following conditions were not included as participants;
- • Patients with nephropathy, retinopathy, diabetic foot, phenylketonuria, maple syrup urine disease
- • Participants with acute and chronic kidney disease, kidney stone,
- • Participants with history of acute liver injury (e.g., hepatitis) or severe cirrhosis
- • Diabetic patients with obesity, cardiovascular diseases, pregnancy
- • Participants taking nutritional supplements and other medicines
About University Of Lahore
The University of Lahore is a leading academic institution dedicated to advancing healthcare research and education. With a robust commitment to scientific inquiry, the university sponsors clinical trials aimed at enhancing medical knowledge and improving patient outcomes. Leveraging its state-of-the-art facilities and interdisciplinary expertise, the University of Lahore collaborates with healthcare professionals and researchers to conduct innovative studies that address pressing health challenges. Through its clinical trial initiatives, the university strives to contribute to evidence-based practices and foster advancements in clinical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Faisalabad, Punjab, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported